#Id: 10456
#Unit 4. Cell Communication and Cell Signaling
A highly specific inhibitor imatinib (Gleevec), which
binds directly to the active site of the ABL kinase and holds it in an inactive conformation to inhibit its kinase activity, is lethal to CML cells